Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium

Journal of Thoracic and Cardiovascular Surgery

Volumn 120, Issue 4, 2000, Pages 707-711

  Evora, Paulo R B ^a   Pearson, Paul J ^a   Chua, Yeow Leng ^a   Discigil, Berent ^a   Schaff, Hartzell V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HEMOGLOBIN; HYALURONIDASE; N(G) METHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DOG; DRUG MECHANISM; FEMALE; HEART PROTECTION; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

EID: 0033771174     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2000.108905     Document Type: Article

References (20)

1. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion
2. Intravenous injection of hyaluronidase in acute myocardial infarction: Preliminary report of clinical and experimental observations
3. Active drainage of cardiac lymph in relation to reduction in size of myocardial infarction: An experimental study
4. Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase: A coded, placebo-controlled animal study
5. Minimal amounts of hyaluronidase in HTK or UW solution substantially improve the recovery of preserved hearts
6. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
7. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets
8. Nitric oxide: An endogenous modulator of leukocyte adhesion
9. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide (abstract)
10. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase
11. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes
12. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries
13. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries
14. Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle
15. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro
16. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation
17. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
18. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin
19. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
20. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation